Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 2542

1.

Viral interference between hepatitis B, C, and D viruses in dual and triple infections in HIV-positive patients.

Morsica G, Bagaglio S, Cicconi P, Capobianchi MR, Pellizzer G, Caramello P, Orani A, Moioli C, Rizzardini G, Uberti-Foppa C, Puoti M, Monforte AD; Hepa I.C.o.N.A the Icona Foundation Study Groups.

J Acquir Immune Defic Syndr. 2009 Aug 15;51(5):574-81. doi: 10.1097/QAI.0b013e3181add592.

PMID:
19590432
2.
3.

Replication status and histological features of patients with triple (B, C, D) and dual (B, C) hepatic infections.

Mathurin P, Thibault V, Kadidja K, Ganne-Carrié N, Moussalli J, El Younsi M, Di Martino V, Lunel F, Charlotte F, Vidaud M, Opolon P, Poynard T.

J Viral Hepat. 2000 Jan;7(1):15-22.

PMID:
10718938
4.

Longitudinal evaluation of viral interactions in treated HIV-hepatitis B co-infected patients with additional hepatitis C and D virus.

Boyd A, Lacombe K, Miailhes P, Gozlan J, Bonnard P, Molina JM, Lascoux-Combe C, Serfaty L, Gault E, Desvarieux M, Girard PM.

J Viral Hepat. 2010 Jan;17(1):65-76. doi: 10.1111/j.1365-2893.2009.01153.x. Epub 2009 Aug 4.

PMID:
19682317
5.
6.

Coinfection with hepatitis viruses and outcome of initial antiretroviral regimens in previously naive HIV-infected subjects.

De Luca A, Bugarini R, Lepri AC, Puoti M, Girardi E, Antinori A, Poggio A, Pagano G, Tositti G, Cadeo G, Macor A, Toti M, D'Arminio Monforte A; Italian Cohort Naive Antiretrovirals Study Group.

Arch Intern Med. 2002 Oct 14;162(18):2125-32.

PMID:
12374521
7.

Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.

Rai RR, Mathur A, Mathur D, Udawat HP, Nepalia S, Nijhawan S, Mathur A.

Trop Gastroenterol. 2007 Jan-Mar;28(1):19-23.

PMID:
17896605
8.

Does treatment of hepatitis B virus (HBV) infection reduce hepatitis delta virus (HDV) replication in HIV-HBV-HDV-coinfected patients?

Sheldon J, Ramos B, Toro C, Ríos P, Martínez-Alarcón J, Bottecchia M, Romero M, Garcia-Samaniego J, Soriano V.

Antivir Ther. 2008;13(1):97-102.

PMID:
18389903
9.

Dominant replication of either virus in dual infection with hepatitis viruses B and C.

Koike K, Yasuda K, Yotsuyanagi H, Moriya K, Hino K, Kurokawa K, Iino S.

J Med Virol. 1995 Feb;45(2):236-9.

PMID:
7539830
10.

Hepatitis B, C seroprevalence and delta viruses in HIV-1 Senegalese patients at HAART initiation (retrospective study).

Diop-Ndiaye H, Touré-Kane C, Etard JF, Lô G, Diaw P, Ngom-Gueye NF, Gueye PM, Ba-Fall K, Ndiaye I, Sow PS, Delaporte E, Mboup S.

J Med Virol. 2008 Aug;80(8):1332-6. doi: 10.1002/jmv.21236.

PMID:
18551596
11.

Interference of replication between hepatitis B and C viruses in patients infected with HIV.

Yang RR, Gui X, Chen XY, Zhu Y.

J Med Virol. 2011 Jul;83(7):1159-64. doi: 10.1002/jmv.22102.

PMID:
21567419
12.

Virological and clinical aspects of HBV-HCV coinfection in HIV positive patients.

Filippini P, Coppola N, Pisapia R, Martini S, Marrocco C, Di Martino F, Sagnelli C, Filippini A, Sagnelli E.

J Med Virol. 2007 Nov;79(11):1679-85.

PMID:
17854026
13.
14.

High prevalence of dual or triple infection of hepatitis B, C, and delta viruses among patients with chronic liver disease in Mongolia.

Tsatsralt-Od B, Takahashi M, Nishizawa T, Endo K, Inoue J, Okamoto H.

J Med Virol. 2005 Dec;77(4):491-9.

PMID:
16254981
15.

Molecular epidemiology of hepatitis B, C, D and E viruses among children in Moscow, Russia.

Abe K, Hayakawa E, Sminov AV, Rossina AL, Ding X, Huy TT, Sata T, Uchaikin VF.

J Clin Virol. 2004 May;30(1):57-61.

PMID:
15072755
16.

Longitudinal evaluation reveals a complex spectrum of virological profiles in hepatitis B virus/hepatitis C virus-coinfected patients.

Raimondo G, Brunetto MR, Pontisso P, Smedile A, Maina AM, Saitta C, Squadrito G, Tono N; Associazione Italiana Studio Fegato Cooperative Group.

Hepatology. 2006 Jan;43(1):100-7.

PMID:
16323213
17.

High rates of active hepatitis B and C co-infections in HIV-1 infected Cameroonian adults initiating antiretroviral therapy.

Laurent C, Bourgeois A, Mpoudi-Ngolé E, Kouanfack C, Ciaffi L, Nkoué N, Mougnutou R, Calmy A, Koulla-Shiro S, Ducos J, Delaporte E.

HIV Med. 2010 Jan;11(1):85-9. doi: 10.1111/j.1468-1293.2009.00742.x. Epub 2009 Jul 29.

18.

A multicenter study of viral hepatitis in a United States hemophilic population.

Troisi CL, Hollinger FB, Hoots WK, Contant C, Gill J, Ragni M, Parmley R, Sexauer C, Gomperts E, Buchanan G, et al.

Blood. 1993 Jan 15;81(2):412-8.

19.

Role of hepatitis C virus in dual and triple hepatitis virus infection.

Liaw YF.

Hepatology. 1995 Oct;22(4 Pt 1):1101-8. Review.

PMID:
7557857
20.

Epidemiological and clinical evaluation of hepatitis B, hepatitis C, and delta hepatitis viruses in Tajikistan.

Khan A, Kurbanov F, Tanaka Y, Elkady A, Sugiyama M, Dustov A, Mizokami M.

J Med Virol. 2008 Feb;80(2):268-76.

PMID:
18098133

Supplemental Content

Support Center